Fhmls Xi, L.P.: insider trades.
Fhmls Xi, L.P. reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 1 open-market purchase ($10.0M) and 0 sales, across 1 company.
- Transactions
- 5
- Purchases (P)
- 1
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- FHMLS XI, L.P.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | TenPercentOwner | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Attovia Therapeutics, Inc. | P | 588,235 | $17 | 6,154,213 | Form 4 |
| 2026-08-06 | Attovia Therapeutics, Inc. | C | 961,322 | — | 5,565,978 | Form 4 |
| 2026-08-06 | Attovia Therapeutics, Inc. | C | 1,189,940 | — | 4,604,656 | Form 4 |
| 2026-08-06 | Attovia Therapeutics, Inc. | C | 1,590,175 | — | 3,414,716 | Form 4 |
| 2026-08-06 | Attovia Therapeutics, Inc. | C | 1,749,192 | — | 1,824,541 | Form 4 |
Questions
What stock did Fhmls Xi, L.P. buy or sell?
Fhmls Xi, L.P. reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 1 open-market purchase ($10.0M) and 0 sales, across 1 company.
Is Fhmls Xi, L.P. the same person as other filers with this name?
This page covers SEC CIK 1911580 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/fhmls-xi-l-p-1911580.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.